Caricamento...
(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
AIM: To investigate the inhibitory efficacy of (125)I-labeled anti-basic fibroblast growth factor (bFGF) monoclonal antibody (mAb) in hepatocellular carcinoma (HCC). METHODS: bFGF mAb was prepared by using the 1G9B9 hybridoma cell line with hybridization technology and extracted from ascites fluid t...
Salvato in:
| Pubblicato in: | World J Gastroenterol |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Inc
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4886378/ https://ncbi.nlm.nih.gov/pubmed/27275095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i21.5033 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|